SpringWorks Therapeutics ... (SWTX)
NASDAQ: SWTX
· Real-Time Price · USD
46.99
0.00 (0.00%)
At close: Jun 30, 2025, 3:59 PM
SpringWorks Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 63.77M | 69.75M | 84.46M | 79.9M | 118.03M | 176.05M | 98.89M | 115M | 102.4M | 67.49M | 476.43M | 69.57M | 81.93M | 103.96M | 93.85M | 84.57M | 95.43M |
Short-Term Investments | 224.1M | 238.23M | 292.16M | 303.99M | 318.55M | 303.15M | 323.52M | 361.71M | 425.74M | 524.72M | 175.51M | 264.97M | 266.34M | 269.54M | 334.06M | 378.21M | 381.99M |
Long-Term Investments | 94.78M | 158.12M | 121.5M | 138.05M | 146.19M | 185.34M | 3.79M | 4.81M | 5.71M | 8.99M | 4.87M | 6.36M | 35.02M | 62.11M | 55.91M | 48.16M | 67.24M |
Other Long-Term Assets | 28.43M | 6.47M | 26.9M | 23.39M | 14.77M | 4.25M | 4.09M | 3.61M | 3.5M | 3.23M | 3M | 3.24M | 3.22M | 3.27M | 3.02M | 2.78M | 3.11M |
Receivables | 40.35M | 46.24M | 32.97M | 24.5M | 15.53M | 5.93M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | 12.42M | 10.21M | 9.83M | 7.72M | 5.22M | 3.1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 15.68M | 16.03M | 15.69M | 15.22M | 14.47M | 12.68M | 9.96M | 7.19M | 9.52M | 7.55M | 5.34M | 7.46M | 7.68M | 9.41M | 5.1M | 4.21M | 4.1M |
Total Current Assets | 356.32M | 380.46M | 435.11M | 431.32M | 471.8M | 500.91M | 432.38M | 483.9M | 537.66M | 599.76M | 657.29M | 342M | 355.95M | 382.91M | 433.01M | 466.99M | 481.51M |
Property-Plant & Equipment | 25.83M | 26.66M | 25.36M | 24.57M | 24.08M | 24.09M | 27.39M | 25M | 22.33M | 18.27M | 16.39M | 14.32M | 11.39M | 4.2M | 3.33M | 2.5M | 2.72M |
Goodwill & Intangibles | n/a | 15.56M | n/a | n/a | n/a | 11.2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 149.04M | 206.81M | 173.77M | 186.01M | 185.03M | 224.88M | 35.27M | 33.43M | 31.54M | 30.48M | 24.27M | 23.92M | 49.63M | 69.58M | 62.26M | 53.44M | 73.07M |
Total Assets | 505.36M | 587.28M | 608.88M | 617.33M | 656.83M | 725.79M | 467.65M | 517.33M | 569.2M | 630.24M | 681.55M | 365.92M | 405.58M | 452.49M | 495.27M | 520.43M | 554.59M |
Account Payables | 14.93M | 12.25M | 9.65M | 7.89M | 7.01M | 7.4M | 5.55M | 3.45M | 6.99M | 8.01M | 4.59M | 2.19M | 1.65M | 3.43M | 2.5M | 3.9M | 2.23M |
Deferred Revenue | n/a | n/a | n/a | 14.63M | 4.65M | 4.14M | 3.24M | 2.36M | 1.69M | 3.31M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | 958K | n/a | 1.06M | 1.16M | 811K | 386K | n/a | 733K | 511K | 327K | n/a | 1.26M | 1.25M | 1.24M |
Other Current Liabilities | 15.6M | 31.22M | 59.73M | 29.66M | 39.15M | 38.46M | 22.13M | 22.21M | 19.17M | 20.1M | 31.21M | 23.05M | 16.4M | n/a | 17.11M | 12.79M | 12.09M |
Total Current Liabilities | 82.27M | 99.99M | 70.61M | 54.5M | 68.92M | 78.17M | 50.28M | 41.91M | 37.75M | 51.05M | 49.49M | 34.91M | 23.24M | 29.97M | 28.1M | 23.01M | 18.73M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 14.66M | n/a | n/a | n/a | 131K | 131K | 131K |
Total Long-Term Liabilities | 5.69M | 6.18M | 5.68M | 6.1M | 20.48M | 21.4M | 22.47M | 23.98M | 24.52M | 21M | 19.66M | 5.27M | 5.54M | 129K | 498K | 832K | 1.16M |
Total Liabilities | 87.96M | 106.17M | 76.3M | 60.6M | 89.39M | 99.57M | 72.75M | 65.89M | 62.27M | 72.05M | 69.15M | 40.19M | 28.78M | 30.1M | 28.6M | 23.84M | 19.89M |
Total Debt | 7.39M | 7.91M | 6.91M | 7.06M | 6.56M | 7.06M | 7.33M | 7.61M | 7.05M | 5.25M | 5.73M | 5.78M | 5.87M | 1.29M | 1.62M | 1.95M | 2.27M |
Common Stock | 8K | 7K | 7K | 7K | 7K | 7K | 6K | 6K | 6K | 6K | 6K | 5K | 5K | 5K | 5K | 5K | 5K |
Retained Earnings | -1.24B | -1.15B | -1.08B | -1.02B | -982.42M | -895.03M | -800.71M | -721.27M | -643.35M | -569.93M | -495.75M | -423.36M | -354.31M | -292.51M | -236.44M | -195.4M | -148.39M |
Comprehensive Income | 442K | 304K | 1.61M | -520K | -113K | 1.19M | -313K | -352K | -162K | -767K | -1.51M | -1.82M | -1.46M | -312K | 24K | 25K | 53K |
Shareholders Equity | 417.39M | 481.1M | 532.58M | 556.73M | 567.44M | 626.22M | 394.9M | 451.44M | 506.92M | 558.19M | 612.4M | 325.73M | 376.8M | 422.4M | 466.68M | 496.58M | 534.7M |
Total Investments | 318.88M | 396.36M | 413.67M | 450.04M | 464.74M | 488.49M | 323.52M | 361.71M | 425.74M | 529.52M | 180.39M | 271.33M | 301.36M | 331.65M | 389.98M | 426.36M | 449.23M |